Cancer Family
Malignant Respiratory System Neoplasm
CI-CAN-00000249Explore in graph →
2,650 active trials51 approved drugs619 evidence items
- NCIt
- C4571
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000249Explore in graph →
Clinical trials
11,128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,492)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00086827 | Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer | completed | Phase 2 | 36 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2014 | clinicaltrials |
| NCT01000480 | A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer | completed | Phase 2 | 90 | Eli Lilly and CompanyINDUSTRY | 4 | Apr 2, 2014 | clinicaltrials |
| A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) |
| withdrawn |
| Phase 1 / Phase 2 |
| 0 |
| Spectrum Pharmaceuticals, IncINDUSTRY |
| 2 |
| Mar 31, 2014 |
| clinicaltrials |
| NCT00203931 | Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer | terminated | Phase 2 | 55 | University of ChicagoOTHER | 1 | Mar 31, 2014 | clinicaltrials |
| NCT00730925 | Single-arm Trial of BIBW 2992 (Afatinib) in Demographically and Genotypically Selected NSCLC Patients | completed | Phase 2 | 41 | Boehringer IngelheimINDUSTRY | 2 | Mar 26, 2014 | clinicaltrials |
| NCT00984542 | Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer | completed | Phase 2 | 50 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Mar 12, 2014 | clinicaltrials |
| NCT00247416 | Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer | completed | Phase 2 | 60 | Susanne ArnoldOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT01256203 | Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light | withdrawn | Phase 2 | 0 | Pinnacle Biologics Inc.INDUSTRY | 0 | Mar 4, 2014 | clinicaltrials |
| NCT00995761 | Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 48 | Gyeongsang National University HospitalOTHER | 1 | Mar 3, 2014 | clinicaltrials |
| NCT01861223 | Afatinib Plus Nimotuzumb for NSCLC | unknown | Phase 1 / Phase 2 | 50 | Samsung Medical CenterOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT02070497 | Effectiveness of Nursing Case Management for Lung Cancer Patients | completed | Phase 2 | 415 | National Taiwan University HospitalOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT02066038 | Intermittent and Maintenance of Erlotinib in Combination With Pemetrexed/Carboplatin in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation | unknown | Phase 2 | 60 | Sun Yat-sen UniversityOTHER | 0 | Feb 19, 2014 | clinicaltrials |
| NCT01516983 | Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation | completed | Phase 1 / Phase 2 | 15 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Feb 17, 2014 | clinicaltrials |
| NCT00256815 | Combination of Weekly Chest Radiotherapy and Oral Navelbine for the Palliation of Advanced Non Small Cell Lung Cancer: A Phase I Study | completed | Phase 1 / Phase 2 | 35 | Clinical Oncology Research AssociatesOTHER | 1 | Feb 11, 2014 | clinicaltrials |
| NCT00171834 | Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 89 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 5, 2014 | clinicaltrials |
| NCT00256841 | Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy | withdrawn | Phase 1 / Phase 2 | 0 | Clinical Oncology Research AssociatesOTHER | 1 | Jan 29, 2014 | clinicaltrials |
| NCT01356368 | Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung Cancer(Customizing) | terminated | Phase 2 | 3 | National Guard Health AffairsOTHER_GOV | 1 | Jan 22, 2014 | clinicaltrials |
| NCT02039518 | Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients | unknown | Phase 2 | 160 | Fudan UniversityOTHER | 1 | Jan 17, 2014 | clinicaltrials |
| NCT00075374 | Two Regimens of Docetaxel in Treating Patients Who Have Not Received Chemotherapy For Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 6 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 16, 2014 | clinicaltrials |
| NCT01640730 | Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer | terminated | Phase 2 | 1 | KangLaiTe USAINDUSTRY | 1 | Jan 16, 2014 | clinicaltrials |
| NCT00006374 | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | withdrawn | Phase 2 | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Jan 15, 2014 | clinicaltrials |
| NCT00858403 | Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation | terminated | Phase 2 | 7 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jan 15, 2014 | clinicaltrials |
| NCT02036359 | Erlotinib Monotherapy Versus Docetaxel and Cisplatin as Neoadjuvant Therapy in Patients of stageIIIA Lung ca(Oncology) | unknown | Phase 2 | 76 | National Taiwan University HospitalOTHER | 1 | Jan 15, 2014 | clinicaltrials |
| NCT00246181 | Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC(SBF-NSCLC) | completed | Phase 1 / Phase 2 | 117 | Jill DelucaOTHER | 1 | Jan 13, 2014 | clinicaltrials |
| NCT00514293 | Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | 39 | Raghu Nandan, M.D., IncOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00006378 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | completed | Phase 2 | 5 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 9, 2014 | clinicaltrials |
| NCT00487669 | Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 14 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Jan 9, 2014 | clinicaltrials |
| NCT00006877 | Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer | completed | Phase 2 | 30 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 8, 2014 | clinicaltrials |
| NCT00003284 | High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer | unknown | Phase 2 | 30 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00005865 | Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | — | GlaxoSmithKlineINDUSTRY | 3 | Jan 6, 2014 | clinicaltrials |
| NCT00022243 | T138067 in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous Chemotherapy | unknown | Phase 2 | — | TularikINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00030641 | Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | — | Genta IncorporatedINDUSTRY | 3 | Jan 6, 2014 | clinicaltrials |
| NCT00033722 | Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | — | TularikINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT01003899 | A Phase II Trial of Afatinib(BIBW 2992) in Third-line Treatment for Patients With Stage IIIB/IV Adenocarcinoma of the Lung Harbouring Wild-type Epidermal Growth Factor Receptor[EGFR] | completed | Phase 2 | 43 | Boehringer IngelheimINDUSTRY | 1 | Dec 31, 2013 | clinicaltrials |
| NCT01871480 | CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung Cancer | terminated | Phase 2 | 50 | Kunming Medical UniversityOTHER | 1 | Dec 30, 2013 | clinicaltrials |
| NCT01998061 | Continuation of TKI With or Without Chemotherapy Beyond Gradual Progression | unknown | Phase 2 | 20 | Zhejiang UniversityOTHER | 1 | Dec 20, 2013 | clinicaltrials |
| NCT02005120 | Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC | unknown | Phase 2 | 20 | Zhejiang UniversityOTHER | 1 | Dec 20, 2013 | clinicaltrials |
| NCT00006215 | Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | — | AmgenINDUSTRY | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00021008 | ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer | unknown | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Dec 19, 2013 | clinicaltrials |
| NCT00253591 | Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 500 | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00278187 | Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT02016209 | Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer | unknown | Phase 2 | 30 | Zhejiang UniversityOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00004253 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery | unknown | Phase 2 | — | Baptist Health South FloridaOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00005825 | Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | unknown | Phase 2 | — | Raghu Nandan, M.D., IncOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00052325 | Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy | unknown | Phase 2 | — | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00809237 | Hydroxychloroquine and Gefitinib to Treat Lung Cancer | unknown | Phase 1 / Phase 2 | 71 | National University Hospital, SingaporeOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT01017679 | Gefitinib 500mg Versus 250mg in Patients With NSCLC With Stable Disease After a Month Treatment of Gefitinib 250mg | completed | Phase 2 | 96 | Sun Yat-sen UniversityOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT01347424 | Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography | unknown | Phase 2 | 40 | Sun Yat-sen UniversityOTHER | 1 | Dec 9, 2013 | clinicaltrials |
| NCT01533727 | CIK Cell Transfusion Plus Chemotherapy as Adjuvant Therapy for Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) | withdrawn | Phase 2 | 0 | Sun Yat-sen UniversityOTHER | 1 | Dec 9, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Apr 10, 2014source: clinicaltrials